|
TRIM6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.272600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.983600E-01 |
| Normal-vs-Stage2 |
8.634200E-01 |
| Normal-vs-Stage3 |
5.386400E-01 |
| Normal-vs-Stage4 |
5.593800E-01 |
| Stage1-vs-Stage2 |
7.847200E-01 |
| Stage1-vs-Stage3 |
4.236000E-01 |
| Stage1-vs-Stage4 |
4.702400E-01 |
| Stage2-vs-Stage3 |
7.769800E-01 |
| Stage2-vs-Stage4 |
7.429400E-01 |
| Stage3-vs-Stage4 |
9.103600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.861400E-01 |
| Normal-vs-AfricanAmerican |
7.939400E-01 |
| Normal-vs-Asian |
4.859000E-01 |
| Caucasian-vs-AfricanAmerican |
8.002200E-01 |
| Caucasian-vs-Asian |
5.085800E-01 |
| AfricanAmerican-vs-Asian |
8.190200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.314400E-01 |
| Normal-vs-Female |
5.392200E-01 |
| Male-vs-Female |
2.154400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.867400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.273200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.259600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.591000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.184800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.872600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.054400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.458800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.786410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.935800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.999000E-01 |
| Classical-VS-Follicular |
4.218300E-02 |
| Classical-VS-Other |
9.026200E-01 |
| Classical-VS-Normal |
6.146600E-01 |
| Tall-VS-Follicular |
4.427200E-01 |
| Tall-VS-Other |
9.488000E-01 |
| Tall-VS-Normal |
9.329400E-01 |
| Follicular-VS-Other |
6.254000E-01 |
| Follicular-VS-Normal |
1.946360E-01 |
| Other-VS-Normal |
9.814600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.993200E-01 |
| Normal-vs-N1 |
7.870100E-02 |
| N0-vs-N1 |
2.039400E-01 |
|
|
